Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
114,000
Employees114,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
114,000
Employees114,000

ABT Key Statistics

Market cap
216.89B
Market cap216.89B
Price-Earnings ratio
15.70
Price-Earnings ratio15.70
Dividend yield
1.88%
Dividend yield1.88%
Average volume
7.17M
Average volume7.17M
High today
$125.33
High today$125.33
Low today
$124.00
Low today$124.00
Open price
$124.09
Open price$124.09
Volume
1.55M
Volume1.55M
52 Week high
$141.23
52 Week high$141.23
52 Week low
$110.86
52 Week low$110.86

Stock Snapshot

The current Abbott(ABT) stock price is $124.81, with a market capitalization of 216.89B. The stock trades at a price-to-earnings (P/E) ratio of 15.70 and offers a dividend yield of 1.9%.

On 2025-12-24, Abbott(ABT) stock traded between a low of $124.00 and a high of $125.33. Shares are currently priced at $124.81, which is +0.7% above the low and -0.4% below the high.

The Abbott(ABT)'s current trading volume is 1.55M, compared to an average daily volume of 7.17M.

During the past year, Abbott(ABT) stock moved between $110.86 at its lowest and $141.23 at its peak.

During the past year, Abbott(ABT) stock moved between $110.86 at its lowest and $141.23 at its peak.

ABT News

Nasdaq 2d
Abbott Wins FDA Approval For Volt Heart Rhythm Treatment

(RTTNews) - Abbott (ABT) announced on Monday that the U.S. Food and Drug Administration has approved its Volt Pulsed Field Ablation (PFA) system for treating at...

Abbott Wins FDA Approval For Volt Heart Rhythm Treatment
TipRanks 2d
Abbott announces FDA approval of Volt PFA System to treat AFib

Abbott (ABT) announced the U.S. FDA has approved the company’s Volt PFA System to treat patients battling atrial fibrillation. Abbott will soon begin commercial...

Simply Wall St 6d
Miniature Heart Device And Wider Lingo Access Could Be A Game Changer For Abbott

Earlier this month, Abbott announced U.S. FDA clearance and CE Mark for its Amplatzer Piccolo Delivery System, enhancing minimally invasive treatment of patent...

Miniature Heart Device And Wider Lingo Access Could Be A Game Changer For Abbott

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
32.3%
Sell
0%

More ABT News

Nasdaq 6d
Interesting ABT Put And Call Options For August 2026

Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the August 2026 expiration. One of the key inputs that goes into the pri...

Interesting ABT Put And Call Options For August 2026
Simply Wall St 7d
Is Abbott Laboratories Still Attractively Priced After Recent Medical Device Momentum In 2025?

If you are wondering whether Abbott Laboratories at around $126 a share is still a smart buy or if the easy money has already been made, you are not alone. This...

Is Abbott Laboratories Still Attractively Priced After Recent Medical Device Momentum In 2025?
Nasdaq 7d
Abbott Laboratories Shares Cross 2% Yield Mark

Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Abbott Laboratories (Symbol: ABT) were yielding above the 2% m...

Abbott Laboratories Shares Cross 2% Yield Mark

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.